In a significant boost to the biopharmaceutical sector, 24 new projects with a total investment exceeding 2 billion yuan ($280.84 million) have recently been launched in Jiading district, Shanghai.
The signing ceremony for the projects was held at the 2024 Jiading Biopharmaceutical Industry Development Conference on Oct 16.
During the event, the Jiading Biopharmaceutical Industry Innovation Alliance was established and the Annual Development Report on Jiading's Biopharmaceutical Industry was unveiled.
According to the report, Jiading currently houses around 1,500 enterprises focused on production, research, or services in the biopharmaceutical industry. The district's biopharmaceutical industry achieved a total output of 28.54 billion yuan in 2023 and 20.13 billion yuan in the first eight months of this year.
To enhance collaboration, the Jiading Biopharmaceutical Shared Laboratory Platform was also launched during the event, providing access to over a billion yuan worth of experimental equipment. This initiative aims to boost resource sharing and efficiency among research institutions and companies.
At the event, Gao Xiang, head of Jiading district, highlighted Jiading's commitment to fostering an environment conducive to achieving the goal of developing a trillion-yuan biopharmaceutical industry, and called on experts, scholars, researchers, and entrepreneurs to create a win-win future together.